176 related articles for article (PubMed ID: 38342917)
1. Deubiquitinase Mysm1 regulates neural stem cell proliferation and differentiation by controlling Id4 expression.
Xu Z; Qin Q; Wang Y; Zhang H; Liu S; Li X; Chen Y; Wang Y; Ruan H; He W; Zhang T; Yan X; Wang C; Xu D; Jiang X
Cell Death Dis; 2024 Feb; 15(2):129. PubMed ID: 38342917
[TBL] [Abstract][Full Text] [Related]
2. The control of hematopoietic stem cell maintenance, self-renewal, and differentiation by Mysm1-mediated epigenetic regulation.
Wang T; Nandakumar V; Jiang XX; Jones L; Yang AG; Huang XF; Chen SY
Blood; 2013 Oct; 122(16):2812-22. PubMed ID: 24014243
[TBL] [Abstract][Full Text] [Related]
3. Deubiquitinase catalytic activity of MYSM1 is essential in vivo for hematopoiesis and immune cell development.
Liang Y; Bhatt G; Tung LT; Wang H; Kim JE; Mousa M; Plackoska V; Illes K; Georges AA; Gros P; Henneman L; Huijbers IJ; Nagar B; Nijnik A
Sci Rep; 2023 Jan; 13(1):338. PubMed ID: 36611064
[TBL] [Abstract][Full Text] [Related]
4. Id4 Downstream of Notch2 Maintains Neural Stem Cell Quiescence in the Adult Hippocampus.
Zhang R; Boareto M; Engler A; Louvi A; Giachino C; Iber D; Taylor V
Cell Rep; 2019 Aug; 28(6):1485-1498.e6. PubMed ID: 31390563
[TBL] [Abstract][Full Text] [Related]
5. Mysm1 epigenetically regulates the immunomodulatory function of adipose-derived stem cells in part by targeting miR-150.
Wang YH; Huang XH; Yang YM; He Y; Dong XH; Yang HX; Zhang L; Wang Y; Zhou J; Wang C; Jiang XX
J Cell Mol Med; 2019 May; 23(5):3737-3746. PubMed ID: 30895711
[TBL] [Abstract][Full Text] [Related]
6. MYSM1 inhibits human colorectal cancer tumorigenesis by activating miR-200 family members/CDH1 and blocking PI3K/AKT signaling.
Chen X; Wang W; Li Y; Huo Y; Zhang H; Feng F; Xi W; Zhang T; Gao J; Yang F; Chen S; Yang A; Wang T
J Exp Clin Cancer Res; 2021 Oct; 40(1):341. PubMed ID: 34706761
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic control of natural killer cell maturation by histone H2A deubiquitinase, MYSM1.
Nandakumar V; Chou Y; Zang L; Huang XF; Chen SY
Proc Natl Acad Sci U S A; 2013 Oct; 110(41):E3927-36. PubMed ID: 24062447
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic control of dendritic cell development and fate determination of common myeloid progenitor by Mysm1.
Won H; Nandakumar V; Yates P; Sanchez S; Jones L; Huang XF; Chen SY
Blood; 2014 Oct; 124(17):2647-56. PubMed ID: 25217698
[TBL] [Abstract][Full Text] [Related]
9. Deubiquitinase MYSM1 in the Hematopoietic System and beyond: A Current Review.
Fiore A; Liang Y; Lin YH; Tung J; Wang H; Langlais D; Nijnik A
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32344625
[TBL] [Abstract][Full Text] [Related]
10. MYSM1 maintains ribosomal protein gene expression in hematopoietic stem cells to prevent hematopoietic dysfunction.
Belle JI; Wang H; Fiore A; Petrov JC; Lin YH; Feng CH; Nguyen TTM; Tung J; Campeau PM; Behrends U; Brunet T; Leszinski GS; Gros P; Langlais D; Nijnik A
JCI Insight; 2020 Jul; 5(13):. PubMed ID: 32641579
[TBL] [Abstract][Full Text] [Related]
11. Control of B cell development by the histone H2A deubiquitinase MYSM1.
Jiang XX; Nguyen Q; Chou Y; Wang T; Nandakumar V; Yates P; Jones L; Wang L; Won H; Lee HR; Jung JU; Müschen M; Huang XF; Chen SY
Immunity; 2011 Dec; 35(6):883-96. PubMed ID: 22169041
[TBL] [Abstract][Full Text] [Related]
12. The critical role of histone H2A-deubiquitinase Mysm1 in hematopoiesis and lymphocyte differentiation.
Nijnik A; Clare S; Hale C; Raisen C; McIntyre RE; Yusa K; Everitt AR; Mottram L; Podrini C; Lucas M; Estabel J; Goulding D; ; ; Adams N; Ramirez-Solis R; White JK; Adams DJ; Hancock RE; Dougan G
Blood; 2012 Feb; 119(6):1370-9. PubMed ID: 22184403
[TBL] [Abstract][Full Text] [Related]
13. Deubiquitinase Mysm1 regulates macrophage survival and polarization.
Zhao X; Huang XH; Dong XH; Wang YH; Yang HX; Wang Y; He Y; Liu S; Zhou J; Wang C; Jiang XX
Mol Biol Rep; 2018 Dec; 45(6):2393-2401. PubMed ID: 30386973
[TBL] [Abstract][Full Text] [Related]
14. A role for the histone H2A deubiquitinase MYSM1 in maintenance of CD8
Förster M; Boora RK; Petrov JC; Fodil N; Albanese I; Kim J; Gros P; Nijnik A
Immunology; 2017 May; 151(1):110-121. PubMed ID: 28066899
[TBL] [Abstract][Full Text] [Related]
15. Interaction of Deubiquitinase 2A-DUB/MYSM1 with DNA Repair and Replication Factors.
Kroeger C; Roesler R; Wiese S; Hainzl A; Gatzka MV
Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32466590
[TBL] [Abstract][Full Text] [Related]
16. 2A-DUB/Mysm1 Regulates Epidermal Development in Part by Suppressing p53-Mediated Programs.
Wilms C; Krikki I; Hainzl A; Kilo S; Alupei M; Makrantonaki E; Wagner M; Kroeger CM; Brinker TJ; Gatzka M
Int J Mol Sci; 2018 Feb; 19(3):. PubMed ID: 29495602
[TBL] [Abstract][Full Text] [Related]
17. Interplay of H2A deubiquitinase 2A-DUB/Mysm1 and the p19(ARF)/p53 axis in hematopoiesis, early T-cell development and tissue differentiation.
Gatzka M; Tasdogan A; Hainzl A; Allies G; Maity P; Wilms C; Wlaschek M; Scharffetter-Kochanek K
Cell Death Differ; 2015 Sep; 22(9):1451-62. PubMed ID: 25613381
[TBL] [Abstract][Full Text] [Related]
18. Loss of p53 compensates osteopenia in murine Mysm1 deficiency.
Haffner-Luntzer M; Kovtun A; Fischer V; Prystaz K; Hainzl A; Kroeger CM; Krikki I; Brinker TJ; Ignatius A; Gatzka M
FASEB J; 2018 Apr; 32(4):1957-1968. PubMed ID: 29203593
[TBL] [Abstract][Full Text] [Related]
19. MYSM1 acts as a novel co-activator of ERα to confer antiestrogen resistance in breast cancer.
Luan R; He M; Li H; Bai Y; Wang A; Sun G; Zhou B; Wang M; Wang C; Wang S; Zeng K; Feng J; Lin L; Wei Y; Kato S; Zhang Q; Zhao Y
EMBO Mol Med; 2024 Jan; 16(1):10-39. PubMed ID: 38177530
[TBL] [Abstract][Full Text] [Related]
20. MYSM1 Is Essential for Maintaining Hematopoietic Stem Cell (HSC) Quiescence and Survival.
Huo Y; Li BY; Lin ZF; Wang W; Jiang XX; Chen X; Xi WJ; Yang AG; Chen SY; Wang T
Med Sci Monit; 2018 Apr; 24():2541-2549. PubMed ID: 29694335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
